Biotech | March 09, 2022
Novo Nordisk expands research collaboration for biologic medicines
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
